Avian Polyomavirus

Overview, Taxonomy, and Structural Characteristics of Avian Polyomavirus

Avian polyomavirus (APV) is recognized as one of the most significant viral agents affecting a broad spectrum of bird species, especially within the psittacine families. Historically documented since the mid‐20th century, APV has gained attention due to its capacity to cause a multifaceted disease that impacts multiple organ systems, manifesting in clinical signs such as feather abnormalities, cutaneous hemorrhages, and hepatic lesions in young birds [8]. The virus’s ability to infect both wild and captive birds, as well as its occurrence in varied geographic settings, from Europe to Asia and Africa, demonstrates a viral ecology that is dynamic and complex [1, 4, 6]. Epidemiological investigations have further underscored the role of avian polyomavirus as an economically significant pathogen in the pet trade and commercial bird breeding, echoing concerns raised by global and regional veterinary health authorities such as the CDC, WHO, and WOAH regarding emerging viral threats in animal populations.

Overview

Avian polyomavirus is a non-enveloped virus with a circular, double-stranded DNA genome, a characteristic that aligns it with other members of the Polyomaviridae family [8]. The disease it causes, often referred to as Budgerigar fledgling disease polyomavirus (BFPyV) when affecting budgerigars, is marked by its acute pathogenicity in young psittacine birds and subclinical infections in adult birds that can serve as reservoirs for ongoing viral transmission [2, 9]. The ecology of APV is both complex and intriguing; studies investigating both captive and wild populations indicate that the virus may circulate with varying degrees of virulence and host specificity. In captive settings, birds often show higher infection rates, suggesting that management practices and environmental factors contribute heavily to the virus’s epidemiology [1, 5]. Furthermore, the virus exhibits a broad host range, affecting not only traditional psittacine species such as budgerigars, cockatiels, and macaws but also non-psittacine birds including pigeons and passerines [7, 14]. This host diversity raises important questions about interspecies transmission, viral evolution, and potential zoonotic implications, aspects that are continuously monitored by international animal health agencies.

Taxonomy

Taxonomically, avian polyomavirus is classified within the family Polyomaviridae, a grouping known for viruses that infect a wide range of vertebrate hosts. The taxonomy of APV is informed by a combination of genetic sequencing, phylogenetic analyses, and comparative molecular studies that focus on conserved regions within the viral genome, particularly the gene encoding the major capsid protein VP1, as well as sequences encoding the viral T-antigen [7, 11, 13]. Isolates from different geographical regions and host species have demonstrated high nucleotide homology, often upwards of 99%, indicating a relatively slow rate of evolutionary change, at least in some regions of the APV genome [2]. Nevertheless, subtle genetic variations can lead to distinct clades or strains that reflect the virus’s adaptation to different avian hosts. For example, phylogenetic analyses have revealed that APV strains isolated from domestic and wild birds often form single homogeneous clades, suggesting that despite its broad host range, the virus undergoes limited host-specific adaptation [4, 11]. Such findings advocate for a comprehensive molecular taxonomy approach that not only categorizes APV based on genetic characteristics but also integrates epidemiological data, as demonstrated in studies conducted in diverse geographical locales such as Iran and Poland [3, 13]. The molecular characterization of APV has also paved the way for improved diagnostic methods, including the development of nested PCR techniques that target specific regions of the VP1 gene, thereby ensuring increased sensitivity and specificity in virus detection, a crucial step for epidemiological surveillance and outbreak control [13].

Structural Characteristics

The structural configuration of avian polyomavirus is a defining feature that underpins its infectivity and pathogenic potential. At the core of its structure is a non-enveloped icosahedral capsid composed primarily of the major capsid protein VP1, which self-assembles into pentameric units to form the overall capsid structure [12]. Unlike mammalian polyomaviruses, APV exhibits unique structural characteristics, a notable feature being the truncated C-terminal region of VP1. This truncation results in the absence of the intercapsomere-connecting β-hairpin, a structural element that in other polyomaviruses is believed to lock the capsid in a rigid conformation [12]. Consequently, APV capsids demonstrate variability in size, a phenomenon that may contribute to differences in virus stability and immune recognition. The absence of the stabilizing β-hairpin not only sets APV apart from its mammalian counterparts (such as JC polyomavirus and simian virus 40) but also suggests that the capsid assembly dynamics in avian species might be more flexible, thereby influencing the virus's ability to traverse host immune defenses and cellular barriers.

Further investigations using cryogenic electron microscopy have provided detailed insight into the arrangement and spatial organization of VP1 pentamers in APV. These studies have revealed that, although the overall topology of the capsid is conserved, subtle differences in the inter-capsomere interactions exist, potentially contributing to the variability in capsid dimensions observed in different APV isolates [12]. In addition to VP1, the minor capsid proteins VP2 and VP3 play pivotal roles in the virus’s structural integrity and infectivity. Their precise spatial positioning has been a subject of considerable interest, with recent structural analyses suggesting a plug-like density at the base of the VP1 pentamers, a feature that is hypothesized to correspond to not only VP2 and VP3 but, in APV, also a minor capsid protein known as VP4 [12]. The presence of VP4, which is unique to avian polyomaviruses, may be implicated in the distinct pathogenesis observed in infected birds, potentially influencing the mechanisms by which the virus enters host cells and establishes infection.

The architecture of the APV genome itself, a small, circular double-stranded DNA molecule, facilitates a compact coding strategy that allows for the synthesis of multiple proteins from overlapping reading frames. This genomic efficiency ensures that key regulatory and structural proteins are produced in sufficient quantities during infection, enabling the virus to effectively hijack host cellular machinery for its replication. Moreover, the conserved genomic regions used for molecular diagnostics, particularly those involved in encoding VP1, underscore the dual importance of these structural elements in both the biology of the virus and in the development of sensitive detection methodologies [7, 10]. Analyses of complete genome sequences from various isolates, such as those recovered from pigeons and finches, have illuminated the evolutionary pressures acting on these structural genes, highlighting areas under strong selective conservation as well as regions of variability that might be linked to host-specific adaptations [7, 10].

By integrating detailed genomic and structural data, researchers have begun to unravel the complex interplay between APV’s taxonomic classification, its molecular evolution, and its unique structural features. Such comprehensive analyses are not only essential for advancing our understanding of virus–host interactions but also form the basis for future strategies in vaccine development and disease management. Given the economic and ecological ramifications of APV outbreaks, particularly in contexts where avian trade and conservation intersect, the combined insights from taxonomy and structural biology serve as a critical foundation for both applied and theoretical investigations into this important pathogen.

Molecular Pathogenesis and Virus-Host Interaction Mechanisms

Avian polyomavirus (APV) is a circular, double-stranded DNA virus that poses a significant threat to a variety of bird species, particularly among psittacine families and other avian hosts. At the molecular level, the pathogenesis of APV involves a finely tuned series of interactions between viral components and host cell machinery. These interactions determine not only the initial attachment and entry of the virus but also subsequent steps including replication, assembly, immune modulation, and, ultimately, disease manifestation [8, 12].

Viral Structure and Capsid Protein Dynamics

The viral capsid is a critical determinant of host tropism and pathogenicity. APV encodes major structural proteins, most notably VP1, which forms the pentameric structures essential for receptor binding and cellular entry. Cryogenic electron microscopy studies have noted that while VP1 is largely conserved across polyomaviruses, APV exhibits a unique truncated C-terminus that results in the absence of an inter-capsomere β-hairpin, a structural element typically observed in mammalian counterparts. This absence is postulated to lead to increased variability in capsid assembly and particle size, potentially influencing both viral attachment efficiency and the immune system’s ability to recognize the virus [8, 12]. In addition, emergent evidence suggests that the plug-like densities detected at the base of VP1 pentamers may incorporate the minor capsid protein VP4, which is unique to avian polyomaviruses and likely plays a role in stabilizing the capsid or facilitating subversion of host responses [12].

Viral Entry and Intracellular Trafficking

Once the viral particle attaches to the host cell surface, likely via sialic acid receptors or other specific glycoproteins, the capsid undergoes conformational changes triggering endocytosis. The virus is subsequently trafficked to the nucleus, where the viral genome is released for replication. Studies in specific pathogen-free (SPF) chickens infected with the APV-20 strain have demonstrated that the viral load in various tissues is positively correlated with the infection dose, which implies that multiple rounds of cell entry and amplification occur in a dose-dependent manner [2]. In young and immunologically immature birds, such as nestlings, this process is especially detrimental, often leading to rapid development of cytopathological changes within the liver, kidney, and spleen [9, 14].

Viral Replication and Host Cell Cycle Interference

Once inside the nucleus, APV commandeers the host’s replication machinery to propagate its double-stranded DNA genome. The viral large T-antigen, although less characterized in APV compared to mammalian polyomaviruses, is believed to interfere with the cell cycle, promoting S-phase entry to create an environment conducive to viral replication. In certain experimental models, it has been observed that the replication efficiency and the ensuing pathological impact vary with the age and immunologic status of the host, suggesting that host cell cycle regulation and innate immune responses significantly modulate infection outcomes [2, 9]. The relatively slow evolution of APV in specific regions, as noted in molecular epidemiological studies from China and Iran, may partly stem from these conserved interactions with the host cell cycle machinery [2, 7, 13].

Host Immune Response and Viral Evasion Strategies

A critical aspect of APV pathogenesis is its ability to persist in the host through immune evasion. Several studies have documented the detection of viral DNA in apparently healthy adult birds, such as budgerigars, where virus-neutralizing antibody titers were consistently present, suggesting that subclinical or latent infections are common [16]. This persistent infection state indicates that APV has evolved mechanisms to modulate the host immune response. One possibility is the interference with antigen presentation or the downregulation of major histocompatibility complex (MHC) molecules, although explicit mechanisms remain to be fully elucidated. The interplay between APV and other co-infecting viruses, notably beak and feather disease virus (BFDV), further complicates the host immune landscape, potentially facilitating viral persistence and enhancing tissue tropism [1, 15].

In cases where the viral infection does progress to overt disease, the host’s inflammatory response appears to be a double-edged sword. While inflammation is aimed at clearing the infection, its overactivation can contribute to extensive tissue damage. Necropsy studies of infected birds have revealed multifocal hemorrhages and necrosis in several organs, including the liver and kidneys, which are also sites of high viral load [9, 14]. Such observations underscore the potential for APV to induce immunopathological damage, a phenomenon that might be driven by both direct viral cytotoxicity and the immune system’s attempt to limit viral dissemination.

Tissue Tropism and Host Specificity

The tissue distribution of APV within the host is extensive, indicating a systemic infection in many cases. Molecular analyses have demonstrated widespread presence of viral DNA across multiple organ systems, irrespective of the clinical presentation. For instance, studies have detected APV in organs ranging from the spleen to the gastrointestinal tract, with evidence suggesting that lower viral loads in breeding birds may reflect a degree of immune control or differential tissue susceptibility [16]. The variable pathogenic effects observed in different bird species, from highly lethal outcomes in nestlings to subclinical infections in adult birds, highlight the complex interplay of viral replication kinetics, host immune competence, and perhaps genetic factors influencing receptor expression [9, 14].

Virus-Host Co-evolution and Intrahost Variability

The genomic sequencing of several APV strains has illuminated the minimal variance in key regions, such as the VP1 gene, across different hosts and geographical regions [7, 10, 13]. This genetic stability suggests a long co-evolutionary history between APV and its avian hosts. Nonetheless, slight nucleotide changes, particularly within the VP1 gene, may confer subtle variations in receptor binding affinity or immune recognition, potentially influencing the virus-host dynamic on a microevolutionary scale. Such intrahost variability may be critical for the persistence of the virus in avian populations and may explain the sporadic nature of disease outbreaks despite widespread subclinical infections [7, 13]. Regulatory institutions such as the World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) have underscored the need for enhanced surveillance and a deeper understanding of these mechanisms, especially in the context of economically significant pathogens in the poultry and pet bird industries.

Interaction with Cellular Signaling Pathways

Emerging data also suggest that APV may interact with host cellular signaling pathways that regulate apoptosis and cell stress responses. The dysregulation of these pathways can facilitate viral replication while impairing normal cellular function, leading to cytopathic effects. Although the molecular details of these interactions have yet to be fully characterized in APV, parallels drawn from studies of mammalian polyomaviruses indicate that interference with the p53 tumor suppressor pathway and alterations in the retinoblastoma protein (pRb) function could be involved. The resultant induction of apoptosis or prolonged cell cycle arrest may contribute to the tissue pathology observed in infected birds, especially in cases where high viral loads overwhelm the host’s capacity for tissue repair and regeneration [2, 9].

In summary, the molecular pathogenesis of avian polyomavirus is a multifaceted process governed by complex interactions between viral structural proteins, the host’s cellular machinery, and the immune system. The dynamic interplay between viral entry, replication, host immune modulation, and tissue-specific pathology not only determines the outcome of infection on an individual bird level but also influences the epidemiological patterns observed across diverse avian populations.

Epidemiological Trends and Geographic Distribution of Avian Polyomavirus

Avian polyomavirus (APV) has emerged as a pathogen of significant concern in diverse avian populations, with documented occurrences spanning multiple continents and a range of ecological settings. The virus exhibits a complex epidemiological profile that reflects host diversity, regional differences in husbandry practices, and distinct transmission mechanisms, including horizontal transmission in captive settings and environmental vectors in wild populations. Research conducted over the past decades across Europe, Asia, Africa, and the Americas has revealed both the widespread prevalence of APV and its intricate interplay with viral co-infections, host susceptibility, and geographical stratification.

Regional Prevalence and Epidemiological Patterns in Europe

In Europe, the epidemiological landscape of APV has been characterized by multiple studies evaluating both captive and wild bird populations. A comprehensive investigation in Poland that encompassed wild and captive Passeriformes demonstrated a notable prevalence of APV, with detection rates reaching 29.6% overall. The study highlighted that captive birds, often maintained under high-density conditions, exhibited higher infection rates (37.4%) compared to their wild counterparts (12.5%) [1]. This disparity underscores the role of intensive rearing practices and close proximity in facilitating viral transmission. The Polish data further revealed a significant co-infection rate when exposed to circoviruses, indicating that management practices in captivity may predispose birds to multifaceted viral challenges.

Additional European data from the Czech Republic targeted clinically healthy captive parrots, where a nested PCR-based survey detected APV at a low prevalence of 1.1%, in contrast to a high detection rate of beak and feather disease virus (BFDV) in the same population [5]. This contrast suggests that while APV can be present subclinically, its epidemiological footprint may be comparatively subdued in well-managed captive facilities. Moreover, studies from Japan on imported and domestically bred psittacine birds recorded a 2.7% positivity rate for APV, illustrating that even in regions with established biosecurity measures, APV can persist as an insidious pathogen in seemingly healthy flocks [19]. These disparate rates underline the need for continuous surveillance and stringent biosecurity protocols in mitigating APV’s spread across European breeding and exhibition scenarios.

Asian Distribution and Diverse Transmission Mechanisms

Asia presents a multifaceted picture of APV epidemiology, where geographical and cultural nuances in aviculture contribute to distinct trends. In China, a study investigating an APV strain isolated from Shandong demonstrated that the virus, while genetically conserved with high nucleotide homology (99%) among strains, still resulted in overt clinical symptoms in SPF chickens, manifesting as depression, feather abnormalities, and hepatic lesions, particularly in younger birds [2]. This indicates that APV can cause significant morbidity, with the severity of manifestations being contingent upon the age of the host and the infectious dose received.

Elsewhere in the region, research from Taiwan documented a notable presence of APV in parrots, albeit at a relatively moderate prevalence of around 8.6%. The study’s systematic sampling across northern, central, and southern Taiwan highlighted that APV infections occurred in both household pets and birds from commercial aviaries, with seasonal peaks correlating to the breeding period [15]. This seasonal association is likely a reflection of increased inter-bird contact during reproductive events, which facilitates viral spread.

Iran exhibits its own unique epidemiological dimensions, where investigations in psittacine bird communities revealed an overall APV prevalence of 25%, with young birds under six months being significantly more susceptible to infection [3]. Enhanced molecular techniques, such as two-step nested PCR targeting the VP1 gene, have further elucidated the circulation of diverse APV strains among different bird species, including rosy-faced lovebirds and budgerigars [13]. These findings are emblematic of a dynamic landscape in which APV transmission in Iran is not only influenced by host age and species but also by seasonal and environmental factors that modulate contact rates and viral shedding.

A noteworthy contribution to the understanding of wild bird transmission in Asia comes from a case report in Thailand. The documentation of APV infection in non-budgerigar psittacine birds from a bird farm near Bangkok detailed severe pathological manifestations including multifocal hemorrhages and hepatosplenomegaly in young birds [14]. The microscopic and ultrastructural examinations underscored the virus’s capacity to induce acute organ damage, reinforcing the notion that APV outbreaks in Asian settings can precipitate high morbidity and economic losses in aviculture.

African and Global Perspectives

African data further enriches the global understanding of APV, as exemplified by investigations conducted in Namibia. In a survey of companion birds in Windhoek, Namibia, APV was detected in 7.69% of the sampled birds, with genomic analysis unveiling a single, homogeneous clade among the APV sequences recovered [4]. Unlike the more heterogeneous viral diversity observed in some Asian and European outbreaks, the Namibian isolates suggest a potentially recent introduction or a stable, localized viral population with minimal host-specific adaptation. The lack of correlation between viral phylogeny and the sampled host species implies that APV is capable of moving freely among diverse avian taxa, a dynamic that is of particular concern for regions with high avifaunal biodiversity and active bird trade.

Captive Versus Wild Populations: Trends and Transmission Dynamics

One of the central epidemiological trends that emerges across multiple studies is the differential prevalence of APV in captive versus wild bird populations. In controlled environments, such as commercial breeding facilities and public aviculture exhibitions, the density of birds and the mixed-species housing arrangements significantly enhance the probability of both direct and indirect viral transmission. This is further accentuated by the detection of coinfections, where birds infected with circoviruses or BFDV display an increased likelihood of concurrent APV infection [1, 18]. Vertical transmission dynamics are particularly intriguing; while evidence demonstrates that circoviruses are vertically transmitted in species such as Atlantic canaries and Bengalese munias, similar vertical pathways have not been observed for APV, suggesting that natural transmission routes for this virus are predominantly horizontal in nature [1].

The interaction between APV and other viruses, such as BFDV, has been highlighted in diverse geographical settings. For instance, in Italy, a study on non-traditional companion animals showed that even a relatively low overall prevalence of APV (2.19%) could have significant implications when co-infections were taken into account, particularly in settings where birds are exposed to multiple pathogens during public exhibitions and mixed-species housing [17]. These findings are also echoed in studies from Eastern Turkey and Taiwan, where coinfection rates have lent further credence to the hypothesis that mixed-species environments amplify the epidemiological footprint of APV [6, 15].

Implications for Surveillance and Biosecurity Practices

Given the broad host range and the geographical dispersion of APV, international agencies such as the CDC, WHO, and WOAH have underscored the importance of robust surveillance programs for avian pathogens, particularly those affecting economically critical and biodiversity-rich avian populations. The implementation of molecular diagnostic tools, like nested PCR and viral genome sequencing, has proven indispensable in delineating the epidemiological trends of APV across regions [7, 10, 11]. These techniques enable rapid identification of outbreaks and provide insights into the genetic stability and evolutionary dynamics of the virus, which are crucial for informing vaccine strategies and biosecurity measures [12, 20].

The evidence of APV circulation across continents, from the high-density breeding facilities in Europe to the dynamic, mixed-species aviaries in Asia and the genetically conserved strains in Africa, reflects both the adaptability of the pathogen and the critical need for integrated surveillance systems. The data collectively suggest that while captive breeding environments are particularly vulnerable to sustained viral transmission, wild populations play a fundamental role in the maintenance and dissemination of APV across ecological landscapes [16, 19]. Furthermore, the identification of unique molecular signatures within regional viral isolates highlights the evolutionary pressures that shape APV distribution, emphasizing the need for region-specific management practices and international cooperation in biosecurity enforcement.

Within this broad landscape, the role of factors such as seasonal variation, host demographics (especially age-related susceptibility), and vertical versus horizontal transmission dynamics cannot be understated. The interplay of these factors not only determines the immediate impact of APV outbreaks on individual flocks and species but also informs long-term strategies for disease control and prevention in both commercial and wild bird populations. As the aviculture industry continues to expand globally, and in light of increased interactions between wild and domesticated species, the epidemiological trends of APV demand continuous monitoring and proactive management in order to safeguard avian health worldwide.

Diagnostic Approaches and Molecular Detection Methods

The diagnostic landscape for avian polyomavirus (APV) has rapidly evolved with the advent of refined molecular techniques and advanced pathogen detection strategies. A myriad of studies have illustrated that PCR‐based techniques, particularly nested and two-step nested PCR, are the gold standard in detecting APV from a variety of tissues and biological samples. These molecular assays target conserved viral genomic regions, commonly including the VP1 gene, whose sequences serve not only for pathogen identification but also for phylogenetic analysis and epidemiological tracking [1, 13].

Polymerase Chain Reaction (PCR) and Nested PCR

PCR remains the cornerstone for APV detection, with numerous investigations employing both single-round and nested methods to enhance sensitivity and specificity. Nested PCR, in particular, has been frequently utilized due to its capacity to detect low viral loads in samples that may otherwise yield false negatives with conventional PCR. For instance, studies on captive and wild birds have demonstrated the utility of nested PCR in screening organ samples, eggs, and cloacal swabs, thereby allowing the detection of APV even in early or subclinical stages of infection [1, 6]. The nested approach involves the initial amplification of a broad target region followed by a secondary, more specific amplification, which increases the detection rate and helps differentiate APV from other co-circulating pathogens such as circoviruses or psittacine beak and feather disease virus (PBFDV) [1, 9, 15].

Moreover, the development of a two-step nested PCR protocol, specifically targeting the VP1 gene, has furthered the accuracy of APV diagnostics. Such sophisticated assays have allowed for subsequent sequencing and phylogenetic analyses to map viral diversity and elucidate strain relationships across different bird species and geographic regions [13]. The adoption of these refined molecular approaches aligns with guidelines from prominent bodies such as the CDC and WOAH, which stress the importance of sensitive and specific diagnostic methods for economically significant pathogens that impact both animal health and biodiversity.

Quantitative Analysis and Viral Load Correlation

Several studies have highlighted the correlation between viral load and infection dose through quantitative PCR (qPCR) techniques. For example, experimental inoculation studies in specific pathogen-free (SPF) chickens reveal that increased viral loads in tissues correspond with higher infection doses, thereby underscoring the importance of quantitation in understanding the pathogen’s kinetics and tissue tropism [2]. Although qPCR techniques were not the central theme in all investigations, the ability to quantify viral DNA provides valuable insights related to disease progression and immune status. Such quantitative data also serve as a foundation for assessing vaccine efficacy and guiding public health strategies supported by agencies like the FAO.

Integration of Sequencing and Phylogenetic Analysis

Detection by PCR is frequently complemented by sequencing technologies, particularly Sanger sequencing, to confirm the identity of the amplified product. The sequence data acquired not only affirm the presence of APV but also offer a deeper understanding of the virus's genetic drift and evolutionary patterns. For example, complete genome sequencing of APV strains isolated from both psittacine and non-psittacine birds has elucidated that strains circulating in certain regions exhibit high nucleotide homology, as seen in APV isolates sharing 99% sequence identity with previously reported strains [2, 7]. Furthermore, phylogenetic reconstruction using these sequences has enabled researchers to map the clades circulating within and between populations, providing crucial epidemiological evidence of virus movement and transmission dynamics [13]. The detection of mutations, even if minimal (such as the 0.98% mutation rate noted in some VP1 sequences [13]), is important for determining potential changes in virulence or vaccine escape, which is a significant concern in zoonotic and economically critical pathogens as noted by WHO guidelines.

Histopathology and Electron Microscopy as Adjunct Diagnostics

While molecular diagnostics dominate the landscape, traditional histopathological methods continue to play an indispensable role in APV detection, particularly when evaluating fatal outbreaks or unusual clinical presentations. Histopathologic examinations often reveal characteristic intranuclear inclusion bodies in affected tissues, such as liver and spleen, which can direct subsequent molecular analyses [9, 14]. In some instances, transmission electron microscopy (TEM) has been utilized to directly visualize icosahedral, non-enveloped virions, providing definitive morphological evidence of APV infection. For example, TEM examination in one study not only confirmed the presence of APV virions in affected nestlings but also added a layer of diagnostic confirmation to the PCR findings [14]. These methods, although more labor-intensive, are critical in scenarios where rapid molecular diagnostics may not be feasible and remain endorsed by international organizations such as the WOAH for thorough pathogen characterization in veterinary diagnostics.

Serological Methods and Virus-Neutralizing Antibody Titers

Beyond nucleic acid detection, serological assays have also been instrumental in diagnosing APV, especially when monitoring breeding populations or in cases of inapparent infection. The determination of virus-neutralizing (VN) antibody titers through serologic assays provides an indirect measure of prior or current APV exposure. Data from studies on adult budgerigars have revealed that VN assays can exhibit 100% sensitivity, making them a useful adjunct to PCR-based methods [16]. Such serological evaluations help in vaccine efficacy studies and in assessing the immune status of entire flocks, supporting vaccine rollout strategies that are also evaluated by agencies like the CDC in the context of emerging infectious diseases.

Integration into Field and Surveillance Diagnostics

Integrating these molecular and serological diagnostic methods into routine surveillance has been essential for early detection and control of APV outbreaks in both captive and wild bird populations. The high sensitivity of nested PCR assays, combined with sequence verification, facilitates the rapid identification of subclinical infections, thereby allowing for prompt implementation of biosecurity measures in aviculture and the pet trade [6, 17]. This integration is especially critical in mixed-species settings and public exhibitions, where interspecies transmission dynamics have been noted [17]. The combined approach of PCR, sequencing, histopathology, and serology provides a comprehensive diagnostic framework that serves as a model for future surveillance protocols endorsed by international organizations concerned with animal health and zoonotic potential.

Overall, the multifaceted diagnostic approaches for APV, ranging from advanced PCR techniques to serological assays and ultrastructural methods, reflect the concerted effort of the veterinary research community to address the challenges posed by this pathogen. These diagnostic innovations not only deepen our molecular understanding of APV but also form the backbone of surveillance and control strategies that are critical for managing economically and ecologically impactful diseases.

Transmission Dynamics: Vertical Transmission and Co-Infection Patterns

Vertical Transmission Dynamics

Avian polyomavirus (APV) exhibits a complex transmission dynamic within avian populations, with particular emphasis on the divergence between vertical transmission mechanisms observed in similar pathogens and those demonstrated by APV. While many avian viruses, such as circoviruses, have well-documented vertical transmission routes via eggs and embryos, APV has demonstrated a variable transmission pattern dependent upon host species and environmental conditions. In studies focusing on passerines such as Atlantic canaries and Bengalese munias, molecular analyses have consistently shown an absence of APV DNA in unfertilized eggs, early-stage embryos, and very young chicks (<7 days old) [1]. These findings indicate that APV, unlike its circovirus counterpart, does not utilize the conventional vertical transmission pathway through direct incorporation into the egg cytoplasm.

Instead, APV’s transmission appears to be largely reliant on post-hatch mechanisms. For instance, in experimental settings using SPF chickens, age-dependent susceptibility was observed, with the youngest birds displaying higher viral loads following infection [2]. Although this study did not directly examine vertical transmission in a natural breeding context, it provided further evidence that the window for APV vulnerability may be confined to the time immediately after hatching when the immune system is still under development. This post-hatch susceptibility suggests that, rather than being directly passed from the parent to the offspring via the egg, APV may be introduced later through environmental exposures or feeding behaviors.

Research into APV transmission in wild songbirds has also shed light on non-traditional vertical routes. In one detailed study, nestlings were observed to acquire polyomavirus infections not directly from the egg but through a process involving ectoparasites such as larval blowflies [21]. In this model, the infection is transmitted “upwards” from environmental sources after the chicks hatch, and further dissemination occurs among adult birds via the cloacal shedding of infected young. Such a mechanism represents an indirect vertical transmission route that mimics traditional horizontal transmission but occurs within the familial context. This nuance in APV transmission dynamics exemplifies the complexity of virus-host interactions in natural ecosystems, where a combination of parent-to-offspring interactions, nest microenvironments, and ectoparasite vectors can contribute significantly to the epidemiological profile of the virus.

While research from several geographic regions has not demonstrated classical vertical transmission of APV through eggs in cages or captivity [1, 14], differences in management practices and environmental conditions might alter the transmission potential. Regulatory bodies such as the World Organisation for Animal Health (WOAH) emphasize strict biosecurity measures in commercial aviculture, especially when evidence suggests that even subclinical infections in adult birds can potentiate further spread through parental care behaviors. This underscores the importance of differentiating between direct vertical transmission (which appears minimal or absent for APV based on current literature) and environmentally mediated or “secondary” vertical transmission routes that might facilitate the maintenance of the virus in both captive and wild populations.

Co-Infection Patterns

In addition to its unique vertical transmission dynamics, APV frequently occurs as part of co-infection complexes in avian species. Such co-infections can have significant implications on disease presentation and epidemiological outcomes. Numerous studies have reported co-infection of APV with other viral pathogens, such as circovirus and psittacine beak and feather disease virus (PBFDV), across a wide range of avian hosts encompassing both captive and wild populations [1, 15, 17, 18]. The simultaneous presence of these viruses often complicates the clinical picture, with affected birds sometimes exhibiting overlapping clinical signs that include feather abnormalities, immunosuppression, and hepatic distress.

For example, in captive passerines in Poland, a remarkable finding was the higher frequency of co-infections in these settings compared to wild populations, with up to 25.1% of captive birds harboring both APV and circovirus concurrently [1]. This is in stark contrast to the 7.7% observed in wild birds, highlighting the influence of husbandry practices on viral dynamics. The close proximity of birds in aviaries and the increased opportunities for cross-species contact in captive settings create an environment that is highly conducive to viral transmission. Such conditions are likely to favor the simultaneous establishment of infections with multiple pathogens, thereby increasing the overall viral load and potentially exacerbating the severity of clinical disease.

Furthermore, molecular epidemiology studies conducted in non-traditional companion animal settings have documented similar co-infection patterns. In Italy, for instance, APV was identified alongside other pathogens in a subset of cases, and risk factors such as participation in public exhibitions and housing in mixed-species settings were associated with higher infection rates [17]. These findings not only highlight the role of environmental and management factors in the establishment of co-infections but also raise the possibility of interspecies transmission events that further complicate the disease ecology of APV.

In regions such as eastern Turkey and Taiwan, co-infection rates with APV and PBFDV have drawn attention to the potential synergistic effects of viral interactions. One study in eastern Turkey found APV in over 23% of samples, with notable co-infection in budgerigars where both APV and PBFDV were detected [6]. Similarly, research in Taiwan documented an APV/PBFDV co-infection rate of approximately 12% in commercial aviaries [15]. The interaction between these viruses may influence the host’s immune response, facilitating chronic infections or altering the progression of clinical disease. Immunosuppressive effects prompted by one virus could potentially make the host more vulnerable to secondary infections, creating a cycle that enhances viral persistence within the flock.

The phenomenon of co-infection is further complicated by the interplay of viral genetics and host susceptibility. In some instances, as evidenced by molecular characterizations of APV strains isolated from various avian hosts, co-infection events may lead to viral recombination, possibly giving rise to new genotypes with altered pathogenic profiles [11, 13]. This genetic interplay is of particular concern from an epidemiological perspective, as emergent strains with increased virulence or altered host range could have significant implications for both avian health and the economic stability of aviculture industries. Regulatory institutions such as the Centers for Disease Control and Prevention (CDC) and the Food and Agriculture Organization (FAO) have long emphasized the importance of comprehensive surveillance programs to monitor such developments, especially in economically critical sectors.

The interactions between APV and co-circulating viruses thus represent a dynamic field of study. In multi-species aviaries, where birds are often asymptomatic carriers, the silent circulation of APV along with other pathogens can create a reservoir of infection that poses challenges for disease control. Proactive screening and biosecurity measures, strategies advocated by global health organizations, are essential to mitigate the risks associated with co-infections in both commercial and non-traditional companion animal settings.

Collectively, the investigation into APV transmission dynamics illustrates that while traditional vertical transmission via eggs is not a predominant route for APV, alternative mechanisms involving environmental influences and familial interactions play a critical role. Simultaneously, the occurrence of co-infections with other avian viruses highlights the multifactorial nature of viral ecology in birds, necessitating integrated approaches in diagnostics, management, and biosecurity to address these multifaceted threats.

Clinical Manifestations in Infected Avian Species

The clinical scenario associated with avian polyomavirus (APV) infection is complex, with manifestations varying widely depending on the host species, age, and overall immunologic status of the bird. In psittacine species such as parrots, cockatiels, and budgerigars, where polyomavirus disease has been extensively documented, the clinical picture can range from subclinical infections with minimal detectable symptoms to overt manifestations that may affect multiple organ systems [3, 7]. Particularly in young, immunologically immature birds, APV infections often progress to a severe course characterized by a range of clinical signs that include depression, drowsiness, abnormal feather development, and in some instances, sudden death [2, 9].

In experimental infection models using specific-pathogen-free (SPF) chickens, infection with an APV strain has induced noticeable depression, drowsiness, and a clustering behavior indicative of systemic malaise. Despite the absence of considerable mortality in these controlled experiments, the observed clinical signs underscore the virus’s potential to compromise the welfare of young birds, particularly those with vulnerable immune systems [2]. In companion birds, detailed case reports, such as those involving cockatiels and budgerigars, illustrate that APV can precipitate acute hepatic and splenic abnormalities coupled with systemic signs of illness [9, 14].

Clinical presentations are often linked to the virus’s tissue tropism, where the replication of virus within specific organs stimulates an inflammatory response with resultant organ dysfunction. A characteristic finding, for instance, in nestling cockatiels is the rapid, almost fulminant, onset of disease where sudden death may occur in birds as young as 4- to 6-days old [9]. These nestlings, while showing generally non-specific clinical signs such as loss of appetite and listlessness, may also exhibit signs of abdominal distension and cutaneous hemorrhages that reflect the internal organ compromise induced by the virus [9].

Moreover, in psittacine species such as the Blue Fronted Amazon parrot, APV infection has been associated with unusual clinical events like severe anemia, a finding that deviates from the traditional profile of the viral infection characterized by feather and beak abnormalities [22]. Such anemia likely arises from the virus-induced disruption of normal hematopoiesis, hepatic involvement where liver necrosis occurs, and possible immunologic dysregulation that collectively contribute to a reduced production of blood cells. This expands the clinical spectrum of APV beyond the more frequently reported cutaneous and liver lesions, suggesting that APV may also target or indirectly affect the hematologic system [22].

In a series of cases from non-budgerigar psittacine birds, lesions such as multifocal hemorrhages in subcutaneous tissues, heart, liver, and the bursa of Fabricius have been reported. The bursa, crucial for B-cell development in birds, when involved, could predispose the bird to secondary infections due to an impaired immune response [14]. In these cases, the manifestation of organ-specific lesions, particularly in the liver and spleen, is consistent with histopathologic observations that reveal extensive necrosis and intranuclear inclusion bodies within infected cells, a hallmark of APV infection [9, 14]. These inclusion bodies, predominantly located in hepatic and renal cells, reflect intensive viral replication and are associated with the clinical severity observed in infected individuals.

Another critical aspect of the clinical picture is the possible influence of coinfections. Studies have documented the presence of coinfections with other viral agents, notably beak and feather disease virus (BFDV). In these contexts, APV infection may exacerbate the clinical severity, as coinfected birds often present with compounded signs including more pronounced feather dystrophy, immune suppression, and multisystem organ involvement [5, 18]. This interplay suggests that APV might act synergistically with other pathogens to undermine the overall health status of the bird, thereby complicating the clinical management and prognostication.

In wild and captive passerines, subclinical infections are not uncommon; however, even in these cases, viral DNA is readily detected in multiple organ systems, indicating a widespread, yet latent infection state. Although these birds may not exhibit overt clinical signs under optimal conditions, stressors such as breeding, nutritional deficiencies, or additional infectious challenges can precipitate acute clinical disease [1, 21]. This subclinical persistence, as evidenced by widespread detection in apparently healthy adult budgerigars, raises concerns regarding virus shedding and the subsequent risk of transmission to younger and more susceptible individuals [16]. The notion that viral load is positively correlated with the dose of infection, particularly during the early stages of life, further implicates the pediatric population as a key demographic in the dissemination and pathogenesis of APV [2].

In companion birds maintained in environments such as aviaries or public exhibitions, the interaction among diverse species, coupled with close-contact housing conditions, potentiates the spread of APV [6, 17]. Clinically, these birds may manifest signs that, while initially subtle, include feather irregularities, decreased vigor, and digestive disturbances such as prolonged retention of undigested food [22]. Radiographic examinations occasionally reveal skeletal or visceral organ enlargement, particularly of the liver and kidney, findings that correlate with the underlying viral hepatitis and nephritis processes triggered by the infection.

Tissue distribution studies elucidate that APV is not confined to a single organ; rather, it exhibits a marked tropism for tissues such as the liver, kidney, and spleen [16]. Hepatic necrosis, often coupled with focal hemorrhages, is a recurrent pathological outcome in cases where the virus is particularly virulent. Necropsy findings reveal that infected birds typically have an enlarged, mottled liver with diffuse areas of necrosis and hemorrhage. Histologically, these lesions are marked by the presence of intranuclear inclusion bodies, indicative of active viral replication and cellular damage [9]. The pathological spectrum extends to include myocarditis and nephritis where inflammatory infiltrates and focal necrosis further compromise organ function [14].

The involvement of the kidney, often demonstrated by both gross and microscopic lesions, not only underscores the virus’s multi-organ impact but also highlights potential disruptions in fluid and electrolyte homeostasis, a condition that could predispose birds to secondary infections or exacerbate systemic clinical deterioration [14]. In certain instances, the virus appears to compromise the integrity of the vascular endothelium, promoting hemorrhage and edema that compound the overall clinical picture.

Given these diverse clinical manifestations and pathological outcomes, it is evident that APV infection poses significant challenges not only in terms of disease management but also in the broader context of avian health and zoonotic disease surveillance. Institutions such as the CDC, WHO, and WOAH underscore the need for rigorous biosecurity measures in avicultural settings, especially considering that the spread of such economically important pathogens can have far-reaching consequences across both commercial and wildlife sectors.

Pathological Outcomes in Infected Avian Species

From a pathological standpoint, APV infection manifests with distinctive lesions that are detectable at both macroscopic and microscopic levels. In fatal cases involving psittacines, autopsy findings typically reveal severe hepatic necrosis with diffuse hemorrhages, splenic damage, and variable kidney and heart involvement [9, 14]. Hematoxylin and eosin staining of tissue sections from lethal cases illustrates extensive liver necroses, with cellular debris and inflammatory infiltrates that outline the extent of damage attributable to the virus [2]. In addition, techniques such as transmission electron microscopy (TEM) have documented the presence of approximately 45 nm icosahedral, non-enveloped viral capsids within the nuclei of infected cells, a finding that reinforces the diagnosis and supports the direct cytopathic effects of APV [14].

In some cases, birds exhibit a chronic course of infection where the persistence of viral DNA is noted across multiple organ systems. The detection of APV DNA in ostensibly healthy adult budgerigars suggests a state of inapparent infection; however, the concomitant observation of low-level inflammatory responses raises the possibility that chronic, subclinical tissue damage is ongoing, even in the absence of overt clinical signs [16]. Moreover, the chronic nature of the infection may predispose the birds to secondary pathogenic challenges, thereby compromising the long-term viability of the infected population. In this regard, the interplay between APV-induced immunosuppression and the appearance of coinfections, such as BFDV as documented in numerous reports, further complicates the pathological landscape [5, 18].

Findings from necropsy studies in infected larval and juvenile birds reveal that the liver and spleen are primary targets of the viral attack. The spleen often displays multifocal hemorrhages, and in some instances, lesions extending to involve the periarteriolar lymphoid sheaths are noted, a possible indication of the virus disrupting normal lymphoid architecture, thereby impairing the immune response [9, 21]. The kidney lesions, manifested as soft areas of pallor and focal necrosis, further support the systemic nature of the infection. Additionally, reports of abdominal distension and hydropericardium in experimental models hint that the circulatory system may also be indirectly affected by the inflammatory processes induced by APV [2].

In summary, the clinical and pathological outcomes observed in APV-infected avian species are multifaceted and underline the significant impact of this viral agent on avian physiology. The variations in clinical presentations, from subtle subclinical infections in adult birds to acute, fatal manifestations in nestlings, highlight the necessity for vigilant monitoring and comprehensive diagnostic strategies to detect and control outbreaks effectively, particularly in settings where birds of diverse species are housed in proximity.

Prevention, Control Strategies, and Future Directions in Avian Polyomavirus Research

Avian polyomavirus (APV) poses a significant challenge to both captive and wild bird populations, with varied clinical outcomes ranging from subclinical infections to severe, fatal disease in susceptible avian hosts. Given its ability to compromise both economical and biodiversity aspects in poultry and companion bird industries, understanding and implementing effective prevention and control strategies is paramount. Extensive research, including molecular epidemiology and structural analyses, provides a solid foundation for integrated management strategies that combine vaccination, biosecurity measures, and advanced diagnostics, in line with global animal health guidelines advocated by organizations such as the CDC, WHO, and WOAH.

Biosecurity and Management Measures

Implementation of strict biosecurity protocols remains a cornerstone in the control of APV infection. Studies demonstrate that infection rates are significantly higher in captive birds than in wild counterparts, suggesting that density, species mixing, and inadequate isolation practices contribute heavily to viral transmission [1, 17]. Practically, this necessitates rigorous screening of new acquisitions, isolation of infected individuals, and the minimization of interspecies interaction, particularly in multi-species aviaries and exhibitions where birds from diverse origins converge [17]. In commercial breeding facilities and pet trade centers, enhanced biosecurity protocols should include routine disinfection of enclosures and equipment, regular monitoring of flock health via PCR-based assays, and strict quarantine measures for incoming birds to prevent drag-along spread from asymptomatic carriers [5, 19].

Additionally, a proactive strategy involving public health agencies and regulatory bodies such as the WOAH can foster uniform guidelines for avian health management. Such collaboration ensures that surveillance data can be integrated into national and international databases, informing targeted interventions that reduce the likelihood of cross-border viral introductions and outbreaks. Best practices, including regular veterinary audits and enhanced training for bird keepers and breeders, are essential to limit viral circulation within local flocks [1, 17].

Vaccination Strategies

Vaccination represents a promising avenue for the control of APV infections, particularly in species that are highly susceptible to severe disease manifestations. A pivotal study demonstrated the efficacy and safety of an inactivated APV vaccine across multiple psittacine species and chickens [20]. Vaccinated birds developed robust virus-neutralizing antibody responses, which correlated with a significant reduction in viral replication upon challenge exposure. With these encouraging findings, vaccination campaigns should be considered a viable adjunct to biosecurity measures, especially in high-risk environments such as breeding facilities, pet trade operations, and large-scale commercial farms.

The vaccine development process has benefited from detailed genetic and structural insights into the virus. For instance, cryogenic electron microscopy studies have elucidated the structure of APV capsid proteins, particularly VP1, and highlighted unique features such as a truncated C-terminus and the possible incorporation of a minor capsid protein, VP4 [12]. Such detailed molecular characterizations not only aid in refining vaccine formulations to enhance immunogenicity but also open avenues for novel subunit or vector-based vaccine designs. Future research should focus on optimizing dosing regimens, investigating long-term immunity, and expanding efficacy trials to encompass a broader range of avian species.

Diagnostic Advances and Molecular Surveillance

Rapid and sensitive diagnostic tests are critical for early outbreak detection and the successful implementation of control strategies. The evolution of two-step nested PCR protocols to detect specific regions of the VP1 gene [13] exemplifies a significant leap in diagnostic sensitivity compared to traditional single-step methods. This improvement allows for the early identification of APV even in birds with subclinical infections, which are well documented in asymptomatic populations [16]. Molecular surveillance, particularly when coupled with sequencing, enables researchers to track viral evolution, identify strain variations, and pinpoint potential sources of infection, as evidenced by phylogenetic studies conducted in diverse regions ranging from Iran to Namibia [4, 13].

Furthermore, integrating these molecular diagnostics into routine veterinary screenings can facilitate timely intervention measures. Regular monitoring not only helps in the early detection of APV but also supports the evaluation of biosecurity and vaccination programs over time. Encouraging coordinated surveillance efforts among researchers, veterinary practitioners, and international agencies such as the FAO can significantly bolster control efforts globally, especially in regions where APV has been recently reported [1, 15].

Epidemiological Considerations and Integrated Control Programs

Understanding the epidemiology of APV is crucial for devising integrated control programs. Epidemiological studies have highlighted several risk factors, including age, species type, and seasonal variations, which influence the infection rates among different bird populations [3, 15]. Young birds, particularly nestlings and fledglings, often exhibit higher susceptibility due to their immature immune systems, which necessitates enhanced protection strategies for these vulnerable groups [9, 14]. Additionally, the role of vertical and horizontal transmission varies among closely related viral agents; while circoviruses show evidence of vertical transmission in certain species, APV appears predominantly to spread horizontally via direct contact and environmental contamination [1, 21]. These distinctions emphasize the need for species-specific and age-specific control measures.

Control programs should be designed holistically, combining the implementation of vaccination, enhanced biosecurity, and continuous education of bird owners and breeders. Special attention must be paid to the integration of molecular epidemiology data with field observations to guide decision-making processes. For instance, data from Poland and Italy illustrate the need for continuous monitoring, particularly in breeding settings where vertical transmission risks are minimal for APV, yet horizontal spread remains a persistent challenge [1, 17]. Furthermore, the close association between APV and other viral pathogens, such as PBFDV, often complicates clinical diagnosis and requires multipathogen screening protocols to prevent co-infection exacerbation [6, 15]. In these contexts, the enforcement of strict quarantine and screening protocols in exhibition settings and breeders’ facilities is indispensable.

Future Research Directions

Future research in avian polyomavirus should aim to bridge the gap between molecular pathogenesis, immunology, and practical disease control strategies. An important avenue for future study includes further refinement of vaccine formulations and adjuvants to maximize protective efficacy. Given the demonstrated safety and immunogenicity profiles of current inactivated vaccines [20], subsequent research could explore innovative delivery platforms such as nanoparticle-based vaccines or recombinant viral vector vaccines, particularly for immunocompromised or genetically diverse populations of birds.

Moreover, the application of advanced genomic technologies and high-throughput sequencing in the surveillance of APV promises to shed light on viral mutation rates, host adaptation mechanisms, and potential antiviral targets. The insights gained from complete genome sequences of APV strains recovered from various hosts [7, 10, 11] could inform the design of tailored interventions that address specific regional or species-based viral variants. Studies focusing on the interplay between host immune responses and viral evasion tactics, particularly those involving the disruption of interferon responses and cellular apoptosis pathways, remain a priority. These investigations may also contribute to the development of therapeutic interventions that harness the host’s immune system to counteract infection.

Enhanced collaboration among international agencies, national health authorities, and academic institutions is critical to advancing research and control measures. The establishment of standardized diagnostic criteria and data-sharing platforms, as well as coordinated multicenter vaccine trials, could substantially accelerate the development of effective interventions. In alignment with the recommendations of the WHO and FAO regarding emerging and economically significant animal pathogens, such coordinated efforts are essential for both local and global control of APV.

Finally, the integration of molecular surveillance data into predictive epidemiological modeling could revolutionize preparedness and response strategies. By incorporating variables such as bird species, age distribution, breeding practices, and environmental conditions, robust models could be developed to forecast outbreak scenarios and inform preemptive control measures. These predictive models, validated by real-time field data, would enable rapid, targeted responses to emerging outbreaks, thereby reducing economic losses and preserving avian biodiversity.

Through a multifaceted approach that blends vaccination, stringent biosecurity, advanced diagnostic protocols, and cutting-edge research into viral genomics and immunology, the future of APV control holds promise for mitigating disease impact and improving overall avian health.

References

[1] Ledwoń A, Szotowska I, Dolka I, Turniak J. Occurrence and vertical transmission of avian polyomavirus and circovirus in captive and wild Passeriformes in Poland. BMC Veterinary Research. 2025. DOI: https://doi.org/10.1186/s12917-025-04899-2

[2] Zhai T, Yan J, Wang J, Kong D, Hou L, Deng Y, et al.. Identification of avian polyomavirus and its pathogenicity to SPF chickens. Frontiers in Microbiology. 2024. DOI: https://doi.org/10.3389/fmicb.2023.1320264

[3] Khosravi M, Samakkhah SA, Khoshbakht R, Mamouri KS. Avian Polyomavirus Among Psittacine Birds in Iran: Molecular Detection Rate and Associated Risk Factors. Journal of avian medicine and surgery. 2024. DOI: https://doi.org/10.1029/AVIANMS-D-23-00022

[4] Molini U, Villiers Md, Villiers Ld, Coetzee L, Hoebes E, Khaiseb S, et al.. Investigation and sequence analysis of psittacine beak and feather disease virus and avian polyomavirus from companion birds in Windhoek, Namibia.. Acta Tropica. 2022. DOI: https://doi.org/10.1016/j.actatropica.2022.106739

[5] Valašťanová M, Petříková M, Kulíková L, Knotek Z. Psittacine beak and feather disease virus and avian polyomavirus detection rate in clinically healthy captive birds in the Czech Republic.. Veterinární Medicína. 2021. DOI: https://doi.org/10.17221/22/2020-VETMED

[6] Adiguzel MC, Timurkan M, Cengiz S. Investigation and Sequence Analysis of Avian Polyomavirus and Psittacine Beak and Feather Disease Virus from Companion Birds in Eastern Turkey. Journal of Veterinary Research. 2020. DOI: https://doi.org/10.2478/jvetres-2020-0066

[7] Li Q, Niu K, Sun H, Xia Y, Sun S, Li J, et al.. Complete Genome Sequence of an Avian Polyomavirus Strain First Isolated from a Pigeon in China. Microbiology Resource Announcements. 2019. DOI: https://doi.org/10.1128/MRA.01490-18

[8] Padzil MFM, Razak MA, Abu J. Avian Polyomavirus: A recent update. Jurnal Veterinar Malaysia. 2017. DOI: https://doi.org/10.71118/586636

[9] Tomášek O, Kubíček O, Tukač V. Unusual fatal avian polyomavirus infection in nestling cockatiels (Nymphicus hollandicus) detected by nested polymerase chain reaction. Veterinarni Medicina. 2018. DOI: https://doi.org/10.17221/2002-VETMED

[10] Heenemann K, Sieg M, Rueckner A, Vahlenkamp T. Complete Genome Sequence of a Novel Avian Polyomavirus Isolated from Gouldian Finch. Genome Announcements. 2015. DOI: https://doi.org/10.1128/genomeA.01001-15

[11] Dayaram A, Piasecki T, Chrzastek K, White R, Julian L, Bysterveldt KAv, et al.. Avian Polyomavirus Genome Sequences Recovered from Parrots in Captive Breeding Facilities in Poland. Genome Announcements. 2015. DOI: https://doi.org/10.1128/genomeA.00986-15

[12] Shen P, Enderlein D, Nelson C, Carter WS, Kawano M, Xing L, et al.. The structure of avian polyomavirus reveals variably sized capsids, nonconserved inter-capsomere interactions, and a possible location of the minor capsid protein VP4. Virology. 2011. DOI: https://doi.org/10.1016/j.virol.2010.12.005

[13] Saber PK, Sheikhi N, Brujeni GN, Pourtaghi H. Molecular characterisation of polyomavirus in parrots in Iran. Bulgarian Journal of Veterinary Medicine. 2025. DOI: https://doi.org/10.15547/bjvm.2024-0045

[14] Mamom T, Dumrongsoonthornchai P, Trongwongsa L. Avian Polyomavirus Infection in Non-Budgerigar Psittacine Birds in Thailand - A case report. Wetchasan sattawaphaet = The Thai journal of veterinary medicine. 2010. DOI: https://doi.org/10.56808/2985-1130.2211

[15] Chung S, Chang C, Shen P, Lin W, Ting C, Wu H. Investigation of Avian polyomavirus and Psittacine beak and Feather disease virus in parrots in Taiwan. Wetchasan sattawaphaet = The Thai journal of veterinary medicine. 2021. DOI: https://doi.org/10.56808/2985-1130.3115

[16] Phalen DN, Wilson VG, Graham DL. Organ distribution of avian polyomavirus DNA and virus-neutralizing antibody titers in healthy adult budgerigars.. American Journal of Veterinary Research. 1993. DOI: https://doi.org/10.2460/ajvr.1993.54.12.2040

[17] Baston R, Tucciarone C, Caudullo A, Poletto F, Legnardi M, Cecchinato M, et al.. Molecular Epidemiology of Beak and Feather Disease Virus (BFDV), Avian Polyomavirus (APV-1), Psittacid Herpesvirus 1 (PsHV-1), and Avian Metapneumovirus (aMPV) in Birds Kept as Non-Traditional Companion Animals (NTCAs) in Italy. Animals. 2025. DOI: https://doi.org/10.3390/ani15152164

[18] Dolz G, Sheleby-Elías J, Romero-Zúñiga J, Vargas-Leitón B, Gutiérrez-Espeleta G, Madriz-Ordeñana K. Prevalence of Psittacine Beak and Feather Disease Virus and Avian Polyomavirus in Captivity Psittacines from Costa Rica. Open Journal of Veterinary Medicine. 2013. DOI: https://doi.org/10.4236/OJVM.2013.34038

[19] Ogawa H, Chahota R, Hagino T, Ohya K, Yamaguchi T, Fukushi H. A survey of avian polyomavirus (APV) infection in imported and domestic bred psittacine birds in Japan.. Journal of Veterinary Medical Science. 2006. DOI: https://doi.org/10.1292/JVMS.68.743

[20] Ritchie B, Latimer KS, Leonard J, Pesti D, Campagnoli R, Lukert PD. Safety, immunogenicity, and efficacy of an inactivated avian polyomavirus vaccine.. American Journal of Veterinary Research. 1998. DOI: https://doi.org/10.2460/ajvr.1998.59.02.143

[21] Potti J, Blanco G, Lemus J, Canal D. Infectious Offspring: How Birds Acquire and Transmit an Avian Polyomavirus in the Wild. PLoS ONE. 2007. DOI: https://doi.org/10.1371/JOURNAL.PONE.0001276

[22] Philadelpho NA, Guimarães MB, Ferreira AP. A Case Report of Avian Polyomavirus Infection in a Blue Fronted Parrot (Amazona aestiva) Associated with Anemia. Case reports in Veterinary Medicine. 2015. DOI: https://doi.org/10.1155/2015/350794